AU5483600A - Pharmaceutical materials and methods for their preparation and use - Google Patents
Pharmaceutical materials and methods for their preparation and useInfo
- Publication number
- AU5483600A AU5483600A AU54836/00A AU5483600A AU5483600A AU 5483600 A AU5483600 A AU 5483600A AU 54836/00 A AU54836/00 A AU 54836/00A AU 5483600 A AU5483600 A AU 5483600A AU 5483600 A AU5483600 A AU 5483600A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- methods
- pharmaceutical materials
- pharmaceutical
- materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13891299P | 1999-06-11 | 1999-06-11 | |
US60138912 | 1999-06-11 | ||
PCT/US2000/016140 WO2000076480A2 (en) | 1999-06-11 | 2000-06-12 | Pharmaceutical materials and methods for their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5483600A true AU5483600A (en) | 2001-01-02 |
Family
ID=22484233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54836/00A Abandoned AU5483600A (en) | 1999-06-11 | 2000-06-12 | Pharmaceutical materials and methods for their preparation and use |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1189599A2 (de) |
AU (1) | AU5483600A (de) |
WO (1) | WO2000076480A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001892B1 (en) | 1999-06-11 | 2006-02-21 | Purdue Research Foundation | Pharmaceutical materials and methods for their preparation and use |
US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
JP5364382B2 (ja) | 2006-02-07 | 2013-12-11 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | 遊離チオール部分を有するタンパク質の安定化された組成物 |
CN105126086B (zh) * | 2009-07-28 | 2019-05-14 | 夏尔人类遗传性治疗公司 | 用于治疗戈谢病的组合物和方法 |
MX361231B (es) | 2012-03-02 | 2018-11-30 | Shire Human Genetic Therapies | Composiciones y usos de las mismas para tratar la enfermedad de gaucher tipo iii. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
US4990216A (en) * | 1987-10-27 | 1991-02-05 | Fujitsu Limited | Process and apparatus for preparation of single crystal of biopolymer |
US5075291A (en) * | 1989-11-22 | 1991-12-24 | Ici Americas Inc. | Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
GB9411129D0 (en) * | 1993-06-16 | 1994-07-27 | Ici America Inc | A crystalline polyol composition |
FR2742164B1 (fr) * | 1995-12-11 | 1999-01-29 | Beghin Say Eridania | Sucre microcristallin : composition et methode d'obtention |
-
2000
- 2000-06-12 EP EP00939811A patent/EP1189599A2/de not_active Withdrawn
- 2000-06-12 AU AU54836/00A patent/AU5483600A/en not_active Abandoned
- 2000-06-12 WO PCT/US2000/016140 patent/WO2000076480A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1189599A2 (de) | 2002-03-27 |
WO2000076480A3 (en) | 2001-04-19 |
WO2000076480A2 (en) | 2000-12-21 |
WO2000076480A9 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
AUPQ969800A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU5440901A (en) | Cosmetic and/or pharmaceutical preparations | |
AU7912100A (en) | Pharmaceutical composition comprising an antigen | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU1267400A (en) | Pharmaceutical moxifloxacin preparation | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
AU3159000A (en) | Phosphorus-comprising materials, their preparation and use | |
AU4328800A (en) | Pharmaceutical formulation | |
AU2438400A (en) | Cosmetic and/or pharmaceutical preparations | |
AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
AU7446900A (en) | Thioalkylamine derivatives and process for the preparation thereof | |
AU4293800A (en) | Cosmetic and/or pharmaceutical preparations | |
AU5875700A (en) | Pigment materials and their preparation and use | |
AUPP672198A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
AU5483600A (en) | Pharmaceutical materials and methods for their preparation and use | |
AUPQ462299A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU2570001A (en) | Pharmaceutical composition and method for its manufacture | |
AU1688099A (en) | Pharmaceutical preparation | |
AU3839900A (en) | Pharmaceutical formulation | |
AU7681498A (en) | Pharmaceutical composition and use thereof | |
AU4543500A (en) | Pharmaceutical compositions and uses | |
AU2880699A (en) | Pharmaceutical compositions and methods for use | |
AU2001260083A1 (en) | New pharmaceutical composition and the process for its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |